Navigation Links
Haemonetics Reports Third Quarter of Fiscal 11
Date:1/31/2011

n $90 million.

Brian Concannon, Haemonetics' President and CEO, said, "I continue to be encouraged by the positive momentum in our business and the excellent operating discipline which has driven strong earnings performance, both in the quarter and year to date. The return to growth in our commercial plasma business is also very encouraging and the sequential growth rates tell the story of a real recovery in demand for our plasma products, which we expect to continue in fiscal 12."

STRATEGIC AND SEGMENT GROWTH HIGHLIGHTSHaemonetics continues to make progress expanding its business.  The Company reported the following highlights:

  • In the quarter, average weekly plasma shipments were up 17% from the low point in the recent plasma downturn which occurred in Q4 of fiscal 10.
  • 47 additional IMPACT™ customers in Q3 fiscal 11 bringing the total number of IMPACT customers to 165, driving accelerated revenue growth in key product lines evidenced by a 21% Q3 growth rate for TEG®  Thrombelastograph® Hemostasis Analyzer disposables.
  • Platelets grew 3% in the quarter and 5% year to date, reflecting strong double digit growth in the Company's emerging markets business units.
  • In the quarter, equipment revenue grew 16% year over year.  Equipment sales are a leading indicator of disposables revenue.
  • The Global Med acquisition integration is proceeding well against its planned schedule and operating income targets.

  • Mr. Concannon added, "We've made great progress in adding IMPACT accounts and these accounts are generating significantly higher growth rates as they implement a differentiated approach to blood management.  I remain confident in our ability to achieve our full year target of 175 IMPACT accounts by fiscal year end."

    As noted, Haemonetics' third quarter fiscal 11 reported revenues were $176.8 million, up 7%.  Reported revenues break down as follows:

    P
    '/>"/>

    SOURCE Haemonetics Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology
    2. Neogen Reports 33% Increase in Net Income
    3. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
    4. New Topical Patent Research Reports Recently Published at MarketPublishers.com
    5. YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387
    6. Oncothyreon Reports Positive Data from Phase 1 Clinical Trial of PI3-Kinase Inhibitor PX-866 in Patients with Relapsed or Refractory Solid Tumors
    7. GeneLink Reports Third Quarter Results
    8. Imagenetix, Inc. Reports Second Quarter 2011 Results
    9. Transgenomic Reports Third Quarter Financial Results
    10. Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results
    11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... ... July 31, 2015 , ... Global Resorcinol ... premium industry insights on the global resorcinol industry. The report highlights the various ... vivid market scenarios and analysis of primary and secondary inputs from the existing ...
    (Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Ralco is ... Center at the Lyon County Fair to be held August 5-9 in Marshall. The ... where their meals come from and how agriculture impacts their daily lives. This unique ...
    (Date:7/30/2015)... ... July 30, 2015 , ... Tronics, ... as Sales & Marketing Director. , With more than 25 years of ... for reinforcing Tronics’ business development activities worldwide. He brings to the company his ...
    (Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine company, ... canine osteoarthritis stem cell product, currently under development for FDA approval. The product ... marketed in the US by Aratana. This product, termed AT-016, is an allogeneic ...
    Breaking Biology Technology:Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3
    ... AUSTIN, Texas , Feb. 15 Dr. Robert Johnson ... at the 5th Annual Stem Cell Summit in New York ... most recent data proving the efficacy of point of care adult stem ... own cells derived from bone marrow to inhibit bone growth in spinal ...
    ... the Nano/Bio Interface Center of the University of ... to electrical current in a molecular circuit. The ... respond to electromagnetic waves by creating surface plasmons ... similar to that of photovoltaic solar cells. ...
    ... ... DNalysis have successfully rolled out PatentSafe, protecting their forensic results and allowing their scientists ... ... 2010 -- Amphora Research Systems is pleased to announce that DNalysis have implemented PatentSafe ...
    Cached Biology Technology:SpineSmith to Present at the 5th Annual Stem Cell Summit 2SpineSmith to Present at the 5th Annual Stem Cell Summit 3Penn material scientists turn light into electrical current using a golden nanoscale system 2Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings 2Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings 3
    (Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
    (Date:7/9/2015)...  Unchained Labs just can,t get enough biologics ... Nano. Avid Nano designs, develops and manufactures highly ... Also today, Unchained Labs UNcaged the pUNk, ... protein sizing system. The pUNk is a high-performance ... size distribution, aggregation population and molecular weight. Its ...
    (Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
    Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
    ... R.I. [Brown University] In a brief paper in ... a new, freely available Web-based program called Spliceman for ... splicing of messenger RNA, potentially leading to disease. ... mutations and computes how likely these single nucleotide variants ...
    ... is key to addressing the major challenges facing humanity in ... Frommer. In a Perspective published in The Plant Cell ... technology is key to transforming plant biology in order to ... of energy into the biosphere, provide food and materials used ...
    ... cardiac pacemakers turns to an unlikely source: vibrations from ... of Michigan designed a device that harvests energy from ... it to electricity to run a pacemaker or an ... the heart to keep it beating in a healthy ...
    Cached Biology News:Will a genetic mutation cause trouble? Ask Spliceman 2The future of plant science a technology perspective 2Heart-powered pacemaker could one day eliminate battery-replacement surgery 2
    ... is primarily used for the preparation of ... for tracing. NH2-Reactive B-Phycoerythrin, a component of ... can easily make a covalent bond with ... without any activation process. Filtration Tube included ...
    Mouse polyclonal antibody raised against a partial recombinant RDH5. NCBI Entrez Gene ID = 5959...
    Mouse monoclonal antibody raised against a partial recombinant KRT4. NCBI Entrez Gene ID = KRT4...
    Mouse monoclonal antibody raised against a partial recombinant ARHGEF11. NCBI Entrez Gene ID = ARHGEF11...
    Biology Products: